Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: VMD (Veterinary Medicines Directorate)
Amoxicillin, Clavulanic Acid
Listow Limited
QJ01CR02
Amoxicillin, Clavulanic Acid
Expired
Revised: October 2012 AN: 00752/2012 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dynaclav Suspension for Injection for Cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: % W/V Amoxicillin (as Amoxicillin trihydrate). 14.0 Clavulanic acid (as Potassium clavulanate). 3.5 EXCIPIENTS: Butylated Hydroxyanisole 0.008 Butylated Hydroxytoluene 0.008 For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Suspension for injection. An off-white suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Dynaclav Injection has a notably broad spectrum of bactericidal activity against the bacteria commonly found in cattle. (a) _In vitro_ Dynaclav Injection is active against a wide range of clinically important bacteria including: Gram-positive: Staphylococci (including beta-lactamase producing strains), Streptococci, Corynebacteria, Clostridia, _Bacillus anthracis_, _Actinomyces bovis_. Gram-negative: _Escherichia coli_ (including beta-lactamase producing strains), _Salmonella_ spp (including beta-lactamase producing strains), _Campylobacter_ spp, _Klebsiella_ spp, _Proteus_ spp, _Pasteurella_ spp, _Fusobacterium_ _ necrophorum_, Bacteroides (including beta-lactamase producing strains), _Haemophilus_ spp, _Moraxella_ spp and _Actinobacillus_ _lignieresi._ Page 1 of 6 Revised: October 2012 AN: 00752/2012 (b) Clinically Dynaclav Injection is effective in treating: Cattle: Respiratory infections Soft tissue infections (e.g. joint/navel ill, abscesses etc.) Metritis Mastitis. 4.3 CONTRAINDICATIONS The product should not be administered to rabbits, guinea pigs, hamsters or gerbils. Caution is advised in its use in other very small herbivores. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should b Διαβάστε το πλήρες έγγραφο